For the biopharma companies poised to profit from new drugs and Covid-19 vaccines it is not an attractive option to keep older drugs that have outlived their patent terms in the running.
000
Why Is Hydroxychloroquine Being Censored And Politicized?
Written by Childrens Health Defense Team
In 2003, severe acute respiratory syndrome (SARS) induced a global panica dress rehearsal, as it were, for Covid-19 in 2020. Although SARS fatalities rapidly petered out (with an eventual worldwide tally of just 774 deaths), concerns about the potential for future spread of the SARS coronavirus (SARS-CoV) left doctors eager to identify effective drugs for treatment and prevention.
In short order, researchers in Europe (2003 and 2004) and at the Special Pathogens Branch of the CDC (2005) published theoretical models and detailed in vitro findings about a drug offering likely prophylactic and therapeutic advantage: chloroquine (CQ).
Following these promising cell culture studies (cited hundreds of times in the scientific literature), researchers around the world continued to explore the antiviral potential of CQ and its more benign analog hydroxychloroquine (HCQ).
A 2006 paper in The Lancet Infectious Diseases again directed attention to CQ as a valuable therapeutic option if SARS re-emerges. In 2014, in the aftermath of the Middle East respiratory syndrome coronavirus (MERS-CoV), researchers at the Anthony-Fauci-led National Institute of Allergy and Infectious Diseases (NIAID) identified 27 existing compounds with activity against both MERS-CoV and SARS-CoV, including CQ and HCQ.
Noting that the screening of approved drugs to identify therapeutics for drug repurposing is a valid approach, the NIAID researchers singled out CQ and one other drug in their closing paragraph as having noteworthy potential to reconfigure the two coronavirus illnesses into a less virulent subclinical infection resulting in less adverse disease outcomes.
This ongoing body of research was clearly at the forefront of many doctors minds when SARS-CoV-2 surfaced this year. In early April, a survey of U.S. physicians found that two-thirds (65%) would prescribe CQ or HCQ to treat or prevent COVID-19 in a family member, and roughly the same percentage (67%) would take it themselves. (The company conducting the survey noted that the best way to get a candid perspective on treatment options from a physician is to ask: Would you give this to your family?)
Another early April survey of over 6,000 physicians in 30 countries found that 37% of respondents who had already treated Covid-19 rated HCQ as the most effective therapy. Apparently, the physicians advising the worlds heads of state are likewise favorably disposed to HCQ. In May, the White House doctor confirmed HCQs excellent benefit-to-risk ratio, and the president of El Salvador not only reported taking HCQ as prophylaxis for Covid-19 himself but asserted that most of the worlds leaders, including President Trump, have been doing the same.
However, in what has turned out to be a gross understatement, the Salvadorean leader also admitted that Sometimes whats recommended to the people is something different than whats recommended to the leaders.
Extra-Scientific Factors
In March, the U.S. readily accepted millions of HCQ tablets donated by pharmaceutical giants Bayer and Sandoz for the U.S. Strategic National Stockpile, and the FDA even granted emergency use authorization for HCQ as a Covid-19 therapy, yet what has been recommended to the American people ever since has most certainly not been HCQ.
In factignoring over five dozen studies (and counting) that have shown CQ or HCQ to be effective against Covid-19 under certain conditionsthe FDA revoked the drugs Covid-19 authorization in June. Meanwhile, the nations number-one-ranked hospital, the Mayo Clinic, currently states on its website that there are no Covid-19 medications or cures.
At this point, when countries using HCQ are displaying a Covid-19 mortality rate that is only one-tenth the mortality rate in countries where there is interference with this medication, such as the United States, it is difficult to deny that an HCQ hit job is taking place both domestically and internationally. Columbia University medical graduate Dr. James Todaro recently declared as much:
If it seems like there is an orchestrated attack thats going on against hydroxychloroquine, its because there is.
For the biopharma companies poised to profit from new drugs and Covid-19 vaccinesincluding the alarming Moderna vaccine co-developed by NIAIDit is not an attractive option to keep older drugs that have outlived their patent terms in the running.
In a Rachel Maddow interview earlier this spring, Columbia Universitys Dr. Ian Lipkin admitted to Maddowwith a grinthat sexy and new and patentable formulations are far more attractive to researchers and investors than tried-and-true, classical sort of methods repurposing drugs and strategies that have already been shown to work.
As a result of the HCQ attacksenabled by the pharmaceutical industry, Fauci and other top health officials, social media giants and captured media, regulatory and scientific journal partnerstens of thousands of Covid-19 patients are dying unnecessarily for reasons having nothing to do with a correct understanding of the science.
The expert making that dire assessmentYale epidemiology professor Harvey Risch, MD, PhDbelieves that in the future, this misbegotten episode regarding hydroxychloroquine will be studied by sociologists of medicine as a classic example of how extra-scientific factors overrode clear-cut medical evidence.
From Essential Medicine To Political Hot Potato
Until this year, CQ and HCQ had an uneventful track record. The German company Bayer developed CQ as an antimalarial in 1934, and HCQ came along about a decade later. In 1955, the FDA approved HCQ for use in the U.S., where the drug has become a staple for the control of certain autoimmune-inflammatory conditions.
The World Health Organization (WHO) includes CQ and HCQ on its list of essential medicines, and both have the reputation of being safe if dosed properly. The most problematic sequelae have been the emergence of drug-resistant malaria and, with long-term use and higher-than-recommended doses, retinopathy.
On March 13, 2020, Dr. Todaro and a coauthor published an online white paper that pointed to the CDCs 2005 chloroquine research and outlined the early and successful use of CQ in Covid-19 patients in South Korea and China.
Noting these promising results and the fact that China had zeroed in on CQ after several screening rounds of thousands of existing drugs, the two physicians urged the U.S. to give Americas medical profession an immediate green light to prescribe CQ and HCQ for Covid-19 patients. Instead, the doctors were met with Googles removal of their white paper.
Around the same time, France reported positive results for HCQ use in combination with the antibiotic azithromycin. The French doctor achieving these results, Dr. Didier Raoult, has been writing for years about the potential to recycle CQ and HCQ for 21st century viral and other infections.
More recently, a Michigan study of patients hospitalized with a Covid-19-related admission and treated early confirmed that both HCQ alone and HCQ plus azithromycin can significantly reduce Covid-19-linked mortality.
Other studies have highlighted the success of a triple combination of HCQ, azithromycin and zinc, a known antiviral. CQ/HCQ rapidly increase intracellular zinc levelsimportant given that the individuals most likely to be Covid-19 patients (the elderly and those with comorbid chronic conditions) tend to be zinc-deficient.
As of late July, a tally of 65 studies around the world indicated that 100% of the studies that assessed HCQ for Covid-19 pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP) or early use showed high effectiveness, as did 61% of the studies examining HCQ use in later stages of illness. Describing a natural experiment in Switzerland, Yales Dr. Risch has noted:
On May 27, the Swiss national government banned outpatient use of hydroxychloroquine for COVID-19. Around June 10, COVID-19 deaths increased four-fold and remained elevated. On June 11, the Swiss government revoked the ban, and on June 23 the death rate reverted to what it had been beforehand.
Even with the mixed results for late use, some clinicians have described clear-cut and dramatically positive clinical responses in individuals treated when breathing was already very difficult and continuing to worsen. In six patients:
[S]ignificant improvement in breathing was seen within about four hours after the first dose, with a complete clinical recovery seen after about an average of three days. [ ] The rapidity with which the shortness of breath evolved in all these individuals strongly suggested that respiratory failure secondary to COVID-19-induced acute respiratory distress syndrome was imminent.
A Nefarious Agenda
The medias flagrant misrepresentation of the HCQ science is bad enough, but the willingness of top-tier journals to finagle the science in an anti-HCQ direction is even more shocking. In early June, scrutiny from dozens of independent scientists forced The Lancet to retract a study it had published just 13 days previouslya study out of thin air that used apparently fabricated data to undermine CQ/HCQ therapy.
The debacle has since become known as #LancetGate. (The same day as the Lancet retraction, the New England Journal of Medicine retracted a separate Covid-19-related study that relied on unverifiable data sourced from the same company that supplied the data for the Lancet study.)
The French health minister used the Lancet study results as justification to ban HCQs use despite widespread public interest in and support for the drug.
Confirming that the anti-HCQ campaign is international in scope, several large-scale, multicenter clinical trials (the WHO-led Solidarity trial, the UK-led Recovery trial and the REMAP-Covid study) that were supposed to lay questions about HCQ safety and effectiveness to rest administered non-therapeutic, toxic and potentially lethal doses of HCQ (four times higher than standard doses) to thousands of study participants.
The trials also selected clinically inappropriate patients who either had severe late-stage illness (Solidarity and Recovery) or were near death and not even able to provide consent in some cases (REMAP). The sponsoring agencies then used the disastrously skewed results to discredit HCQ and unblushingly marshalled the bogus Lancet study (before its retraction) in support of their negative conclusions.
When medical internist and biowarfare expert Meryl Nass, MD conducted a detailed analysis of the study protocols, she concluded that WHO and other national health agencies, and charities, have designed huge clinical trials to assure that hydroxychloroquine will fail to show benefit, and in so doing, conspired to increase the number of deaths in these trials and deprive billions of people from potentially benefiting from a safe and inexpensive drug during a major pandemic.
Therapeutics, Not Politics
In the U.S., physician and Stanford-educated lawyer Simone Gold, MD, JD pointed out in a mid-June interview about HCQs politicization that There was never controversy about hydroxychloroquine right up until March 20, 2020the day that President Trump praised HCQ as a game changer (timestamp 3:42).
This week, Dr. Gold and an accompanying group of frontline doctors from around the U.S. went public on the steps of the U.S. Supreme Court with their frustration about HCQs marginalization. In their video, the doctors reiterated the effectiveness of HCQ, azithromycin and zinc for Covid-19 prophylaxis and early-stage illness and asserted that nobody needs to die.
The video garnered an astonishing 17 million views on Facebook and over 80,000 views on YouTube before the two tech giants (plus Twitter) took it down. The mainstream media then swiftly followed up with pieces designed to character-assassinate the doctors and, ironically, slam them as too political.
Rather than promote the HCQ+azithromycin+zinc combination or other inexpensive therapies that have achieved real-world results, Fauci (Americas doctor) continues to disparage HCQ while painting a grim no end in sight picture in which non-evidence-based lockdowns and social distancing are the only response.
In Faucis recent speeches, it is difficult to find any mention of therapies at all, other than praise for the risky, high-dollar Ebola drug Remdesivir manufactured by Faucis pharmaceutical counterparts. Tested in NIAID-sponsored trials, Remdesivir has failed to deliver any clinically meaningful results for Covid-19 patients.
Fauci, the man who has had continuous job security at the National Institutes of Health since 1968, has dismissed the stunning and health-threatening loss of millions of American jobsnearly 50 million first-time unemployment applications thus faras merely inconvenient.
In a late July speech to cancer doctors, Faucis sole concession to the havoc that his lockdown advice has helped propagate was to dispassionately admit that up to 10,000 extra cancer deaths may result from the cancer screenings that Americans are currently foregoing. The message that ought to be equally distressing to the American public is that a propaganda war against a potentially life-saving medication is being waged for political purposes, not based on medical facts.
Read more at childrenshealthdefense.org
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Please DONATE TODAY To Help Our Non-Profit Mission To Defend The Scientific Method.
Bloggar | Breytt s.d. kl. 01:53 | Slóš | Facebook | Athugasemdir (0)
On May 27, the Swiss national government banned outpatient use of hydroxychloroquine for COVID-19. Around June 10, COVID-19 deaths increased four-fold and remained elevated. On June 11, the Swiss government revoked the ban, and on June 23 the death rate reverted to what it had been beforehand.
slóš
000
After six months of evidence gathering more and more frontline doctors are speaking out against the repressive and unscientific approach of policymakers and bureaucrats who, it seems, are hell-bent on only one outcome: a mass mandatory vaccination program rolled out by their friends in Big Pharma. What could possibly go wrong?
A comprehensive answer to that question is found in Murder By Injection'(1988):The Eustace Mullins Warning For Today.
000
Israels Before & After Proves HCQ Beats COVID19
Written by Elsa Schieder PhD & John O'Sullivan
The Times of Israel reveals an astonishing fact that concerns us all in the battle against the current coronavirus pandemic. The respected newspaper points to that nations mortality data before and after a change in public policy on the use of hydroxychloroquine to treat the symptoms associated with COVID19. That data may be a bitter pill to swallow for fanatical vaccine manufacturers and promoters.
Times of Israel reporter, Barry Shaw, set the stage thus:
Israel congratulated itself on coming through the Wuhan virus pandemic with flying colors. By the end of June, with only 300 plus deaths, we were king of the world. We were allowed to go about our normal daily lives. And then we were hit again. Big time. The death rate rocketed to over 1200.
Shaw then poses the question: what did Israel do differently that could cause this remarkable 400 percent uptick in deaths in this tiny but important middle east country?
And then Shaw concedes the answer:
Local doctors and clinics are being prevented from prescribing a drug that worked before, but is banned now. The drug that dare not speak its name is hydroxychloroquine. Medical experts are forbidden on social media to mention its name. Some have been fired from their professional for daring to suggest that this drug, in combination with others, has saved countless lives.
The banned drug? Hydroxychloroquine (HCQ), used successfully to save tens of thousands of lives wherever doctors are free to prescribe it to patients. Independent researcher, Elsa Schieder, PhD, who has followed these developments intently told Principia Scientific International:
The shock and horror isnt just at the number. Its at the likely cause. In the first wave, HCQ was readily available. Now its banned for early use. Why is Israel, like many other countries, doing this? There is huge evidence for the efficacy of HCQ (plus zinc plus antibiotic) when administered early.
Schieder, like many independent analysts, has been monitoring closely how governments worldwide have been managing their response to the twists and turns of the emerging empirical data and the overall picture shows a stubborn resistance against implementing anything other than a holding pattern of lockdowns, social distancing and other restrictive practices until such time as a COVID vaccine is approved and distributed.
The insanity of this approach is exposed by the increasing number of medical professionals who have seen excellent results with hydroxychloroquine, listed by WHO as one of the safest medicines widely available. But whenever doctors attempt to share their promising findings they are attacked and de-platformed.
As Schieder adds:
We saw that about a month ago with the FrontLine Doctors protest when about 600 American doctors, spoke out on this. Their video got 20 million views in two days.
Then it was pulled by Youtube and Facebook. The main spokesperson was fired from her two emergency room positions. All for promoting a medication all the doctors found effective.
It would be logical to immediately try a drug like this on Covid-19, as there are similar symptoms to treat, notably Covids viral storm which causes severe lung inflammation leading to lung damage.
Schieder points to the exceptional work of such doctors who, in the face of demonization and threats from the powers that be continue to use HCQ, especially right away, at the first onset of respiratory symptoms when the evidence shows greatest efficacy. But HCQ is not the only drug showing very good results. Another safe, long-standing medication is budesonide an anti-inflammatory used for pneumonia and asthma.
It would be logical to immediately try such a safe, proven drug like this on Covid-19 to stem the viral storm which causes severe lung inflammation leading to lung damage. Detailed information about this comes from Dr Richard Bartlett, the West Texas doctor who has heralded the effectiveness of budesonide. In his experience, this drug stops the inflammation from happening.
He sees this treatment as a silver bullet for Covid-19. He claims that many patients feel hugely better after even one treatment.
Its an inhaled steroid that doesnt have the side effects of total body steroids but it has the benefits, he said in an interview. Its like putting out a fire at the base of the fire. Im having patients recover so quickly, says Bartlett, who has claimed 100 percent success.
Though Bartlett has suggested his protocol to at least one local hospital, the treatment was not even tried. Why not? The reason given was that there was no proof it would work on hospitalized patients. Of course, had Dr Bartlett waited for proof, he never would have tried the medication on non-hospitalized people.
In fact, Bartlett has never seen the medicine work so well for anything else:
Its like this medicine was made for this pandemic.
Yet this treatment option like HCQ has not been widely tested. Worse, anything other than a promised (and expensive) Big Pharma vaccine is unjustly suppressed or ridiculed.
After six months of evidence gathering more and more frontline doctors are speaking out against the repressive and unscientific approach of policymakers and bureaucrats who, it seems, are hell-bent on only one outcome: a mass mandatory vaccination program rolled out by their friends in Big Pharma. What could possibly go wrong?
A comprehensive answer to that question is found in Murder By Injection'(1988):The Eustace Mullins Warning For Today.
About the authors: Elsa Schieder, PhD obtained her PhD in Psychology, Sociology, Cultural Theory from Concordia University and was a full-time professor at Concordia and CEGEP John Abbott College, Montreal. Now Elsa is Keynote Speaker and Co-Organizer at Essentials of Freedom Convention.
John OSullivanJohn is CEO and co-founder (with Dr Tim Ball) of Principia Scientific International (PSI). John is a seasoned science writer and legal analyst who assisted Dr Ball in defeating world leading climate expert, Michael hockey stick Mann in the science trial of the century. OSullivan is credited as the visionary who formed the original Slayers group of scientists in 2010 who then collaborated in creating the worlds first full-volume debunk of the greenhouse gas theory plus their new follow-up book.
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Please DONATE TODAY To Help Our Non-Profit Mission To Defend The Scientific Method.
Bloggar | Breytt 24.1.2021 kl. 01:21 | Slóš | Facebook | Athugasemdir (0)
Leitaši aš stofnfrumum og svo stem cells, ķ mķnu bloggi og žetta er śtkoman, sumt tvķtekiš.
Japan, experts focus on the development of induced pluripotent stem cells (iPSCs), which are a novel means to treat a range of degenerative conditions, including those leading to vision loss. This ground-breaking work is possible thanks the government.
Mį ég gera žetta svona til kynningar į nżrri tękni? Žetta er einnig auglżsing fyrir greinina. How artificial intelligence helps get new treatments to patients. https://www.reuters.com/brandfeatures/intelligent-regeneration-in-japan Regenerative medicine
Nišurstöšur fyrir stofnfrumur
6 bloggfęrslur fundust

Magnśs Ver, var ķ fjórgang sterkasti mašur heims, og fór ķ stofnfrumumešferš į hnjįm og var frįbęr eftir ašgerš. Nś er mögulegt aš lękna augnbotna hrörnun. Lausnirnar fram ķ dagsljósiš. Leita aš žeim, sem eru komnir lengst ķ aš leysa mįliš.
Nišurstöšur fyrir stem cell 16 bloggfęrslur fundust Sį įgęti Magnśs Ver, var ķ fjórgang sterkasti mašur heims, og fór ķ stofnfrumumešferš į hnjįm og var frįbęr eftir ašgerš. Hvaš tefur Rįšfrśna ķ aš lįta Ķslendinga njóta ašgeršanna, innan trygginga?

Mikiš er gaman aš sjį lęknana okkar farna aš nota stofnfrumur lķkamans sem geta heilaš flest ķ lķkamanum, ef ekki allt. Fólkiš streymir ķ stofnfrumu ašgeršir og er tilbśiš aš greiša žśsundir dollara fyrir stofnfrumu ašgeršir.
Mér skilst aš sjśkra, mešala leyfisstofnun Bandarķkjanna, FDA vilji fį sķna 2 til 4 milljarša dollara fyrir aš samžykkja mešferšina, en heilsustöšvarnar segja aš žetta sé ekki mešal, ašeins styrking og hjįlp viš byggingarefni lķkamans, stofnfrumurnar, og

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin.
Ķslensk endursögn er komin. (Ķslenska žetta, ?.) 000 Hér fyrri umfjöllun. slóš - https://jonasg-egi.blog.is/blog/jonasg-egi/entry/2226503/ 000 Alternative to Knee Replacement & Surgery

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur.
Ķslensk endursögn er komin. (Ķslenska žetta, ?.) 000 Hér fyrri umfjöllun. slóš - https://jonasg-egi.blog.is/blog/jonasg-egi/entry/2226503/ 000 Alternative to Knee Replacement & Surgery
Nišurstöšur fyrir stem cells
Bloggarar
7 bloggfęrslur fundust

Magnśs Ver, var ķ fjórgang sterkasti mašur heims, og fór ķ stofnfrumumešferš į hnjįm og var frįbęr eftir ašgerš. Nś er mögulegt aš lękna augnbotna hrörnun. Lausnirnar fram ķ dagsljósiš. Leita aš žeim, sem eru komnir lengst ķ aš leysa mįliš.
Nišurstöšur fyrir stem cell 16 bloggfęrslur fundust Sį įgęti Magnśs Ver, var ķ fjórgang sterkasti mašur heims, og fór ķ stofnfrumumešferš į hnjįm og var frįbęr eftir ašgerš. Hvaš tefur Rįšfrśna ķ aš lįta Ķslendinga njóta ašgeršanna, innan trygginga?

Japan, experts focus on the development of induced pluripotent stem cells (iPSCs), which are a novel means to treat a range of degenerative conditions, including those leading to vision loss. This ground-breaking work is possible thanks the government.
Mį ég gera žetta svona til kynningar į nżrri tękni? Žetta er einnig auglżsing fyrir greinina. How artificial intelligence helps get new treatments to patients. https://www.reuters.com/brandfeatures/intelligent-regeneration-in-japan Regenerative medicine

Stofnfrumuašgeršir viršast virka, stofnfrumurnar viršast fara śt ķ lķkamann og endurbyggja hann. Žęr viršast geta breyst ķ ašrar frumur lķkamans og endurnżjaš hann. Fólkiš streymir ķ žessar ašgeršir, og er tilbśiš aš greiša žśsundir dollara fyrir.
Allar slóšir voru breittar ? og virkušu ekki, lagaši strax og ég sį žaš Įtakalķnurnar viršast vera aš FDA vill fį 2 til 4 miljarša dollara til sķn fyrir aš samžykkja mešferšina, en Klķnikarnar, lękningastöšvarnar vilja ekki borga neitt. Viš munum aš žaš

Sprautaš stofnfrumum ķ annaš hnéš, žį varš - dramatic improvement in the knee that received stem cells, but also in their other knee, - Lagar žį gnęgš stofnfruma allan lķkaman?
Ég hef ekki gefiš mér tķma tķma til aš tķna śt orkucellur, gott aš lesa žaš lķka. Nišurstöšur fyrir cell 20 bloggfęrslur fundust "Mayo is unique in having an adipose-derived allogeneic stem cell bank. It provides us with donor mesenchymal stem cells,

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin.
Ķslensk endursögn er komin. (Ķslenska žetta, ?.) 000 Hér fyrri umfjöllun. slóš - https://jonasg-egi.blog.is/blog/jonasg-egi/entry/2226503/ 000 Alternative to Knee Replacement & Surgery

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur.
Ķslensk endursögn er komin. (Ķslenska žetta, ?.) 000 Hér fyrri umfjöllun. slóš - https://jonasg-egi.blog.is/blog/jonasg-egi/entry/2226503/ 000 Alternative to Knee Replacement & Surgery

Ķ žaš minnsta 600 stofnfrumu ašgeršar stöšvar ķ Bandarķkjunum, bjóša stofnfrumu ašgeršir, į yfir eitt hundraš žśsund sjśklingum, aš tališ er. Er žaš ósatt, aš borga žurfi tvo til fjóra milljarša dollara til aš fį samžykki yfirvalda į mešali, ašferš?
slóš Majo Clinic, frekar FDA, gerir stofnfrumu mešferš į hnjįm, og fęr óvęntar nišurstöšur, aš mér skilst, žęr virka. Verš ķ Mayo ķ Rochester, 584.644 kr ķ Bruno ķ Tékklandi, 1.600.000 kr. Ekki endilega samskonar ašgerš, og taka tillit til gengis
0000000000000000
Nišurstöšur fyrir stofnfrumur

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin. Mayo is unique in having stem cell bank.
Nišurstöšur fyrir stofnfrumur 8 bloggfęrslur fundust Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin.

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin.
Ķslensk endursögn er komin. (Ķslenska žetta, ?.) 000 Hér fyrri umfjöllun. slóš - https://jonasg-egi.blog.is/blog/jonasg-egi/entry/2226503/ 000 Alternative to Knee Replacement & Surgery

"Mayo is unique in having an adipose-derived allogeneic stem cell bank. It provides us with donor mesenchymal stem cells, which we mix with recycled autologous cells to - obtain enough cells to fill the patient's cartilage defect without operating twice,"
Ķslanska nešst.* Mayo Clinic offers a unique regenerative medicine approach for repairing knee cartilage, which can be completed in a single surgery. The Food and Drug Administration approved the use of this technique, known as recycled cartilage

We - counted all of the stem cells - made sure they - survive inside - patient, - Most clinics just draw the cells from bone marrow or fat and inject them back into the patient without checking for stem cells, hoping that patients get better,
Ķslenska nešst,* The study was conducted in Mayo’s Human Cell Therapy Lab. Researchers extracted 60 to 90 milliliters of bone marrow from each patient, then filtered it, removed all blood cells, and concentrated it down to 4 to 5 milliliters. The

Sent vorri frįbęru Rįšfrś Svandķsi Svavarsdóttur, og til Sjśkratrygginga Ķslands, į blogginu. Drķfum ķ aš nśverandi ašilar, sem eru aš hjįlpa okkur, fįi kennslu ķ stofnfrumu lękningum, og aš viš njótum įfram okkar góšu og hagkvęmu lęknisžjónustu.
Hvernig mį žaš vera, aš Ķslendingar, og reyndar Noršurlandažjóširnar, fį ekki aš njóta nśtķma lęknisžjónustu? Stofnfrumu ašgeršir, eru framkvęmdar vķtt um veröldina, heimin, en koma ekki til Ķslands og Noršurlandana? Ef spurt er, er sagt aš žetta sé
000000000000000000000
Nišurstöšur fyrir stem cells

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin. Mayo is unique in having stem cell bank.
Nišurstöšur fyrir stofnfrumur 8 bloggfęrslur fundust Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin.

Hér er smį sżnishorn af žvķ aš nś žegar er mögulegt aš lękna augnbotna hrörnun. Drögum lausnirnar fram ķ dagsljósiš. Allir leiti aš žeim, sem eru komnir lengst meš aš leysa mįliš. Ef viš leitum ekki aš žvķ besta, žį finnum viš žaš ekki.
Athugašu, aš žetta er eins og hįlfs įrs gömul grein, žekkingin flżgur įfram. Athuga aš žaš geta veriš margir ašrir meš svipaš, ég žurfti aš leita žó nokkuš til aš finna žetta. Takiš aš ykkur aš leita aš lausnum. Munum aš Nikola Tesla leitaši aš vissum

Stofnfrumuašgeršir viršast virka, stofnfrumurnar viršast fara śt ķ lķkamann og endurbyggja hann. Žęr viršast geta breyst ķ ašrar frumur lķkamans og endurnżjaš hann. Fólkiš streymir ķ žessar ašgeršir, og er tilbśiš aš greiša žśsundir dollara fyrir.
Allar slóšir voru breittar ? og virkušu ekki, lagaši strax og ég sį žaš Įtakalķnurnar viršast vera aš FDA vill fį 2 til 4 miljarša dollara til sķn fyrir aš samžykkja mešferšina, en Klķnikarnar, lękningastöšvarnar vilja ekki borga neitt. Viš munum aš žaš

Stofnfrumuašgeršir viršast virka, stofnfrumurnar viršast fara śt ķ lķkamann og endurbyggja hann. Žęr viršast geta breyst ķ ašrar frumur lķkamans og endurnżjaš hann. Fólkiš streymir ķ žessar ašgeršir, og er tilbśiš aš greiša žśsundir dollara fyrir.
Įtakalķnurnar viršast vera aš FDA vill fį 2 til 4 miljarša dollara til sķn fyrir aš samžykkja mešferšina, en Klķnikarnar, lękningastöšvarnar vilja ekki borga neitt. Viš munum aš žaš voru til mešul, til aš lękna żmsa sjaldgęfa sjśkdóma, en engin vildi

Fór aš leita aš stofnfrumu ašgerš į hné, nįlęgt Boston, styttra flug, og fór aš skoša žetta. (The prices for various treatments vary from $900 to $6,000.) aš 800.000 krónur. Ķslensk endursögn er komin.
Ķslensk endursögn er komin. (Ķslenska žetta, ?.) 000 Hér fyrri umfjöllun. slóš - https://jonasg-egi.blog.is/blog/jonasg-egi/entry/2226503/ 000 Alternative to Knee Replacement & Surgery

"Mayo is unique in having an adipose-derived allogeneic stem cell bank. It provides us with donor mesenchymal stem cells, which we mix with recycled autologous cells to - obtain enough cells to fill the patient's cartilage defect without operating twice,"
Ķslanska nešst.* Mayo Clinic offers a unique regenerative medicine approach for repairing knee cartilage, which can be completed in a single surgery. The Food and Drug Administration approved the use of this technique, known as recycled cartilage

We - counted all of the stem cells - made sure they - survive inside - patient, - Most clinics just draw the cells from bone marrow or fat and inject them back into the patient without checking for stem cells, hoping that patients get better,
Ķslenska nešst,* The study was conducted in Mayo’s Human Cell Therapy Lab. Researchers extracted 60 to 90 milliliters of bone marrow from each patient, then filtered it, removed all blood cells, and concentrated it down to 4 to 5 milliliters. The

Sent vorri frįbęru Rįšfrś Svandķsi Svavarsdóttur, og til Sjśkratrygginga Ķslands, į blogginu. Drķfum ķ aš nśverandi ašilar, sem eru aš hjįlpa okkur, fįi kennslu ķ stofnfrumu lękningum, og aš viš njótum įfram okkar góšu og hagkvęmu lęknisžjónustu.
Hvernig mį žaš vera, aš Ķslendingar, og reyndar Noršurlandažjóširnar, fį ekki aš njóta nśtķma lęknisžjónustu? Stofnfrumu ašgeršir, eru framkvęmdar vķtt um veröldina, heimin, en koma ekki til Ķslands og Noršurlandana? Ef spurt er, er sagt aš žetta sé

Majo Clinic, frekar FDA, gerir stofnfrumu mešferš į hnjįm, og fęr óvęntar nišurstöšur, aš mér skilst, žęr virka. Verš ķ Mayo ķ Rochester*, 584.644 kr ķ Bruno** ķ Tékklandi, 1.600.000 kr. Ekki endilega samskonar ašgerš, og taka tillit til gengis mismunar.
Athuga nešar, * og ** Žaš eru aš minsta kosti 600 stofnfrumu ašgeršar stöšvar ķ Bandarķkjunum, sem bjóša hinar żmsu stofnfrumu ašgeršir, į yfir 100.000, eitt hundraš žśsund sjśklingum, aš tališ er ... there are at least 600 stem cell clinics in the U.S.

A small but growing number of doctors are turning to cutting-edge stem cell therapy as an alterative to knee replacement surgery. This experimental treatment uses bone marrow stem cells from the hip to help regenerate cartilage tissue in the knee.
Til žķn, žeirra sem mįliš varšar, nżrri upplżsingar eru betri. slóš: Alternatives to Knee Replacement Surgery 6.5.2015 | 00:08 https://jonasg-egi.blog.is/blog/jonasg-egi/entry/1728825/ Stem Cells This experimental treatment uses bone marrow stem cells

Hęgt er aš lįta tennur laga sig sjįlfar, og nżjar tennur vaxa į nįttśrulegan hįtt. Ekki gleyma aš leifa bólusetningu viš tannskemmdum. - Grow your own TEETH - dental experts signal end of false gnashers
Grow your own TEETH - dental experts signal end of false gnashers FALSE teeth could soon be a thing of the past after scientists discovered a way of growing a new set. http://www.express.co.uk/life-style/health/628603/grow-new-teeth-false-teeth 000

Alternatives to Knee Replacement Surgery
Hér er ég aš kynna ykkur žessa slóš. Žiš gętuš misst af žessu. Vonandi er žaš leyfilegt. Egilsstašir, 01.05.2015 Jónas Gunnlaugsson Proposed Total Right Knee Replacement Procedure Drawing

I was able to throw away my cane, ... Now I am biking and hiking like a 30-year-old.
Forvitnilegt, žaš vantar ekki aš hśn Patricia Beals 72 ara, er hróšug. Egilsstašir, 01.05.2015 Jónas Gunnlaugsson Ef ég mį ekki birta žetta žį tek ég žaš strax nišur, aš sjįlfsögšu. Stem Cells: Alternative to Knee Replacement?
Bloggar | Breytt s.d. kl. 09:14 | Slóš | Facebook | Athugasemdir (0)
Fjįrmįlakerfiš
000
19.1.2010 | 18:02
Skilaboš ķbśa alžjóšasamfélagsins til Ķslendinga!
000
Fjįrmįlakerfiš er einfalt, ekki lįta flękja žaš til aš blekkja okkur.
Peningar, mynt og sešlar eru fyrirfram slegnar, prentašar nótur, fęranlegt bókhald, meš żmsum upphęšum, til aš hęgt sé aš eiga višskipti, hvar sem er.
Ašeins aš setja "Kreppufléttuna" hans Tómasar Jefferssonar fyrir dóm.
Fjįrmįlakerfiš, bankarnir bjuggu fyrst til veršbólgu, og žjóšin, fólkiš byggši upp landiš.
Bankinn, lįnaši, hann lįnaši ekki neitt, en fęrši fjįrmįlabókhaldiš.
Veršbólgan, eigum viš aš segja kostnašaraukningin, varš til žess aš allar fasteignir uršu mun dżrari.
Sķšan bjó fjįrmįlakerfiš til veršhjöšnun, meš žvķ aš stöšva śtlįn, žaš er aš stöšva aš fęra fjįrmįlabókhald, peningar eru bókhald.
Žį kom strax samdrįttur, og fólkiš missti vinnuna og fyrirtękin misstu žį višskiptavini.
Žegar fólk og fyrirtęki misstu tekjurnar gįtu fólk og fyrirtęki ekki greitt af lįnum sķnum.
Žį reyndu allir aš selja eignir, en bankinn sagši, ég hjįlpa engum aš kaupa.
Fjįrmįlakerfiš, bankinn, sagši fólkinu aš bankinn vęri tómur.
Banki er alltaf tómur.
Banki fęrir ašeins bókhald.
Fjįrmįlakerfiš, bankinn og ekki gleyma lķfeyrissjóšunum, bišu į mešan žeir "hertu aš fólkinu ólina" žaš er byrjušu aš senda uppbošsbeišnir į fólk og fyrirtęki.
Žį reyndu fólk og fyrirtęki aš selja en fjįrmįlakerfiš, bankarnir og lķfeyrissjóširnir vildu ekki hjįlpa neinum aš kaupa.
Fyrirtękja, hśsa og ķbśša eigendur, sem höfšu fengiš tilkynningu um lögtak, reyndu enn aš selja eignir, og bušu eignirnar į 80% verši og sķšan į 50% verši.
Žį sögšu Fjįrmįlafyrirtękin, bankarnir og lķfeyrissjóširnir.
Žiš eruš aš bjóša eignirnar į 50% verši,
Žį er ykkar eign farin.
Og fólkiš sagši, jį žaš viršist vera, žetta eru meiri vandręšin.
Og žį sögšu fjįrmįlafyrirtękin, bankarnir og lķfeyrissjóširnir.
Jį viš skulum hjįlpa upp į ykkur, og taka eignirnar.
Žiš eruš žį laus śr žessum miklu vandręšum, erum viš ekki góšir.
Žarna voru fjįrmįlafyrirtękin, bankarnir og lķfeyrissjóširnir, bśnir aš plata frį eigendunum allar žeirra eignir.
Lįnin, žaš sem fjįrmįlastofnanir, bankarnir og lķfeyrissjóširnir höfšu lįnaš, var ašeins bókhald.
Jęja.
Nś sendu fjįrmįlafyrirtękin, bankarnir og lķfeyrissjóširnir śt tilkynningar til fjölmišlanna, um aš eignir, fjįrmįlafyrirtękja, banka og lķfeyrissjóša hefšu aukist um 500 miljarša sķšasta mįnuš.
Žarna hafši kerfiš, meš žessari brellu, sem Tómas Jefferson sagši okkur frį, hirt allar eignir af fólki og fyrirtękjum.
Ert žś sįttur?
Skammastu žķn ekki aš lįta hlunnfara žig?
Nś er aš bretta upp ermar og lįta žetta fara fyrir dóm og ekki sętta sig viš annaš en aš žeir, žaš er, fjįrmįlafyrirtękin, bankarnir og lķfeyrissjóširnir skili öllu aftur.
Peningalega er žaš engin vandi.
Žetta er jś bara bókhald.
En žau vandręši, ég nota ekki sterkari orš, sem žetta klękjabragš hefur valdiš er grķšarlegt.
Fólkiš mį ekki hętta fyrr en žessi svik og eru skķrš og upplżst og eru dęmd ólögleg,
Žiš eigiš ekki aš sętta ykkur viš aš lįta plata ykkur.
Ekki lįta segja ykkur aš žetta sé löglegt.
Svokallašar eignir hręgammasjóša, eru allar byggšar į žessu, mį ég nota svindli?
Starfsfólkiš ķ žessum fjįrmįlastofnunum skildi ekkert ķ žessu frekar en viš.
Ekki lįta plata žig til aš eltast viš einstaklinga.
Žessu kerfi er stżrt frį alžjóša fjįrmįlakerfinu.
Žaš koma ašilar frį til dęmis Alžjóša gjaldeyrissjóšnum eša OECD og segja,
Žś įtt aš greiša ICAVE eša leysa höftin og lįta hręgammasjóšina komast til śtlanda meš,, mį ég nota oršiš rįnsfengin? eša įrangur klękja fléttunar?
Ef eitthvaš er hér sem er athugavert, žį breyti ér žvķ aš bestu manna yfirsżn.
Egilsstašir, 28.11.2015 Jónas Gunnlaugsson
slóšir
Peningar, sešlar, eru fyrirfram prentaš bókhald, nótur meš mismunandi veršgildi sem rašaš er saman til aš geta greitt einhverja įkvešna upphęš ķ višskiptum.
6.1.2016 | 12:15
Thomas Jefferson sagši okkur žetta allt saman.
Nżtt peningakerfi. Eg. 07.12.2011 jg
Skapararnir og Nś stašreynda trśar fólkiš.
** Bankar framleiša peninga **
Ķbśšalįnasjóšur, lįttu ekki plata žig.
Nótur, kvittanir, peningur er fęranlegt bókhald.
Egilsstašir,19.01.2010 Jónas Gunnlaugsson
Egilsstašir, 19.01.2021 Jónas Gunnlaugsson
Bloggar | Breytt 20.1.2021 kl. 10:30 | Slóš | Facebook | Athugasemdir (1)
Gęti žetta veriš sönn skįldsaga?
Jón, Gunna, Stķna, Pįll og Nķna, öll 12 įra fį verkefni ķ skólanum. Žiš eygiš aš sżna efnahagskerfi gamlafólksins.
Žau setjast nišur, og fara aš velta žvķ fyrir sér, hvernig ętti aš gera žetta.
Fyrst höfum viš engan banka.
Gunna vill kaupa fisk af Jóni og greiša meš kartöflum.
Žį segir Jón, ég į svo mikiš af kartöflum aš ég get ekki tekiš meira af žeim.
Viš eyšum ekki meiri tķma ķ žetta.
Žau įkveša aš Nķna bśi til 10 miša fyrir hvert žeirra.
Žį lętur Gunna Jón fį einn miša fyrir fiskinn.
Allir verši aš fį einhverskonar vinnu til aš fį tekjur, miša.
Einn er bóndi annar fiskimašur, žrišji flutningabķlstjóri, fjórši verslunarmašur og svo Nķna mišastjóri, bókhaldsstjóri, bankastjóri.
Žau sjį fljótt, aš betra er aš hafa nótur, sešla meš mismunandi upphęšum og kalla žį fęranlegt bókhald.
Žį er hęgt aš fara upp ķ Fljótsdal og kaupa hest meš sešlum.
Sį sem seldi hestinn getur fariš meš sešlana og keypt vöru ķ versluninni.
Mišarnir, sešlarnir ganga į milli manna og allir nota žį til aš skiptast į veršmętum.
Nķna bjó til miša eftir žörfum.
Ef einhversstašar var laust fólk, žį fékk rķkiš miša, bókhaldsmiša, peninga, og greiddi bókhaldsmišana, peningana til fólksins, starfsfólksins.
Žį fékk žetta fólk miša, peninga, bókhald til aš geta lifaš, og žjóšfélagiš fékk tvķbreišan veg, tvķbreiša brś og fólkiš lifši į tekjunum viš aš gera gagn.
Mikiš gaman.
Žį vildi einhver eiga bankann og hann gaf öllum brennivķn, og allt gekk eins og ķ sögu, kominn einkabanki.
Einkabankinn žóttist lįna fólkinu, tók vexti og žegar bśiš var aš byggja allt fullt af ķbśšarhśsum, atvinnuhśsnęši, bķlum, hśsgögnum fyrir fólkiš, žį hętti bankinn aš skrifa miša, peninga, peningabókhald.
Žį varš žurrš į mišum, peningum, peningabókhaldi śti ķ žjóšfélaginu.
Žį var ekki hęgt aš skiptast į vinnu og vörum, og allt stöšvašist ķ žjóšfélaginu.
Fólkiš gat žį ekki greitt af lįnunum til einkabankans, og einkabankinn tók allt saman.
Žegar einkabankinn var bśinn aš nį öllu sagši hann.
Nś er nóg af mišum, peningum, peningabókhaldi, fariš žiš śt aš vinna, og eftir 5, 10, 15 įr žį hirši ég allt af ykkur aftur.
Hvaš er hęgt aš kalla okkur fólkiš, sem lętur fara svona meš sig.
Viš segjum ekki, fķfl, asnar, illa upplżst.
Setjum sanna kennslu inn ķ skólana.
Žeir sem vilja blekkja okkur rįši ekki kennsluefninu.
Hįskólar megi ekki fį greitt frį fjįrmįlakerfinu, til aš fjįrmagna prófessors embętti og rįši kennsluefninu.
Žaš į aš kenna žaš sem er satt en ekki spila į lżšinn.
Bankanum er leift aš segja aš hann sé aš lįna okkur veršmętiš.
En, veršmętiš er hugur og hönd fólksins.
Bankanum er leift aš eiga allt sem gert er.
Bankinn er 100% į Rķkinu, fólkinu.
Ef einhversstašar er laus hönd, žį mį banki fólksins, Rķkiš skrifa bókhald, sešla, pening fyrir vinnu fólksins.
Byggja innviši, vegi, brżr, flugvelli, göng ef žś įtt lausa hönd.
Gleymdu ekki aš Big Parma greišir helmingi meira en olķuišnašurinn til aš hafa stjórn į stjórnmįlunum, stjórnmįlamönnunum.
Ef viš fólkiš, til dęmis stéttarfélaugin, bęjarfélögin og Rķkiš kennum sannleika, žį geta stjórnmįlamenn notaš sannleikann lķka.
Ef fólkiš skilur ekki sannleika, hefur ekki veriš kenndur sannleiki, žį skilur žaš ekki stjórnmįlamanninn sem segir satt.
Lęra, lęra, lęra.
Egilsstašir, 18.01.2021 Jónas Gunnlaugsson
Bloggar | Breytt s.d. kl. 19:32 | Slóš | Facebook | Athugasemdir (0)
Tķmabundin yfirtaka hersins į öllum fjölmišlum er lķkleg. (myndband) - (* Dómgreind, skilningi *)
Temporary Military Takeover of All Media Predicted (Video) *Discernment*
Bloggar | Breytt s.d. kl. 01:02 | Slóš | Facebook | Athugasemdir (0)
THE STORM IS UPON USFOR REAL!
Democrats Dire Desperation Reveals
That They Know The Super-Storm Is
About To Make Landfall Inside The BeltwayAND IT IS!
To be completed today after we finish storm-proofing our homes and businesses.
In the meantime, it will serve every Patriot well to read the headlines under Recent Post as today will be the biggest day in Alt Media history and tomorrow will surely be bigger. The data dumps, intel drops and info downloads are so radioactive and these are only a few of the known exposés.
Supreme Court of Italy Reveals Who Stole the U.S. Election
Thank you for your understanding, SOTN readers. You all should be out prepping as well, because we are about to enter extremely turbulent and totally unchartered waters, yes?!
And, theres no stopping the tempestuous period of [NECESSARY] turmoil soon to come upon US.
State of the Nation
January 10, 2021
Bloggar | Breytt s.d. kl. 18:26 | Slóš | Facebook | Athugasemdir (0)
Bloggar | Slóš | Facebook | Athugasemdir (0)
Hógvęr, hugrökk sįl
tekur ekki žįtt ķ lyginni.
Sannleiksorš er meira en heimurinn.
000
Einföld skref hugrakks einstaklings
er aš taka ekki žįtt ķ lyginni.
Eitt orš sannleikans vegur žyngra en heimurinn.
Aleksandr Solzhenitsyn
000
The simple steps of a courageous individual
is not to take part in the lie.
One word of truth outweighs the world.
Aleksandr Solzhenitsyn
Egilsstašir, 02.01.2021 Jónas Gunnlaugsson
Bloggar | Breytt s.d. kl. 10:33 | Slóš | Facebook | Athugasemdir (0)